Mr. Floyd, thank you for your support of Aronex Pharmaceuticals, Inc. I understand your request for more frequent updates; however, there really is not much to talk about publicly. Our four clinical trials are moving along well, and we have a number of major milestones to achieve in 1998.
Early in May, you should be receiving the Company's material for the Annual Meeting which will include the 1997 Annual Report, Form 10-K and Proxy Statement. Hopefully, this will give you more information. Press releases are posted on the web site within 24 hours of their release.
Again, thank you for your patience as we move our products closer to commercialization.
Connie Stout, Manager of Corporate Communications
-----Original Message-----
From: Robert Floyd [SMTP:rfloyd@zianet.com]
Sent: Friday, April 17, 1998 3:35 AM
To: cstout@aronex-pharm.com
Subject: Investor Relations
As an investor, I sure would like more frequent updates as to Aronex's progress in its drug development. |
